Timing of intensive immunosuppression impacts risk of transgene antibodies after AAV gene therapy in nonhuman primates - Samelson-Jones, B J; Finn, J D; Favaro, P; Wright, J F; Arruda, V R (Mol Ther Methods Clin Dev, 2020)